Box Hill Hospital is a teaching hospital in Melbourne. It is one of the seven hospitals that are governed within the Eastern Health network which provides health care services across the Eastern metropolitan area of Victoria.

There are 621 beds in Box Hill Hospital.

During the past decade, Box Hill Hospital conducted 152 clinical trials. In the 10-year time frame, 152 clinical trials started and 74 clinical trials were completed, i.e. on average, 48.7% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 44 clinical trials were completed. i.e. 64.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Box Hill Hospital" #1 sponsor was "Pfizer" with 27 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Neuroscience Trials Australia" with 8 trials sponsored and "ETOP IBCSG Partners Foundation" with 8 trials sponsored. Other sponsors include 165 different institutions and companies that sponsored additional 114 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Box Hill Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 11 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 5 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator, "The Florey Institute of Neuroscience and Mental Health" with 5 trials as a collaborator and "Astellas Pharma Inc" with 4 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 149 trials.

According to Clinical.Site data, the most researched conditions in "Box Hill Hospital" are "Breast Cancer" (11 trials), "Prostate Cancer" (8 trials), "Stroke" (8 trials), "Ulcerative Colitis" (7 trials) and "Alzheimer's Disease" (5 trials). Many other conditions were trialed in "Box Hill Hospital" in a lesser frequency.

Most popular intervention types in "Box Hill Hospital" are "Drug" (202 trials), "Other" (31 trials), "Biological" (20 trials), "Procedure" (9 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (67 trials), "Cisplatin" (6 trials), "Enzalutamide" (6 trials), "Paclitaxel" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Box Hill Hospital" are 206 trials for "All" genders, 13 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 102 active trials in "Box Hill Hospital". 1 are not yet recruiting, 52 are recruiting, 46 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 93 completed trials in Box Hill Hospital, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Box Hill Hospital, 14 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 8 trials that are defined as “Not Applicable".